Live

TACTI-004 Phase III trial

1 articles

Immutep Stock Crashes 82% After Failed Phase III Trial; Law Firm Launches Investor Investigation

GlobeNewswire Inc.

GlobeNewswire Inc.·3h ago·Pomerantz Llp

Immutep Stock Crashes 82% After Failed Phase III Trial; Law Firm Launches Investor Investigation

Immutep stock collapsed 82% after Phase III trial failure. Law firm investigates potential securities fraud regarding disclosure timing and adequacy.

IMMPsecurities fraudclass action lawsuit